PEOPLE - Beiersdorf makes appointment:
This article was originally published in Clinica
Executive Summary
Thomas-Bernd Quaas has been designated as the new board of management chairman of German wound care and consumer products company Beiersdorf (Hamburg). He takes up the role on May 18, and will replace the experienced Rolf Kunisch, who will join the supervisory board. The long-standing Uwe Wolfer will also retire from the management board. Other new board appointees in May will be: Pieter Nota (brands) and Markus Pinger (supply chain).
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.